Firms open Shanghai facilities

June 14, 2004

Bracco is consolidating operations in China. A production plant of Bracco-SINE Pharmaceutical, the joint venture formed by the Italian group with one of China's primary pharmaceuticals companies, is opening in Pudong (Shanghai). The new plant, which

Bracco is consolidating operations in China. A production plant of Bracco-SINE Pharmaceutical, the joint venture formed by the Italian group with one of China's primary pharmaceuticals companies, is opening in Pudong (Shanghai). The new plant, which covers 2000 square meters, will produce contrast media for diagnostic imaging systems. It focuses on the final cycle in contrast media production. Basic substances sent from Italy are processed into solutions, then prepared, sealed, and sterilized into injectible products. The market for contrast media is expected to rise in China by an annual 20% to 30%.

Canadian software developer Cedara has opened a new office in Shanghai. The company's PACS products are already being sold by some of the country's leading medical equipment manufacturers. Cedara's new Chinese office is another step toward establishing a larger presence in the region, according to the company. The Shanghai office will provide local sales, support, and training to the company's Chinese customer base, as well as to customers in the Asia-Pacific region.